Adicet Bio (ACET) Competitors $0.78 -0.04 (-4.99%) Closing price 04:00 PM EasternExtended Trading$0.77 -0.01 (-0.99%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACET vs. ADMA, URI, FAST, GWW, WSO, AIT, WCC, BECN, AL, and GATXShould you be buying Adicet Bio stock or one of its competitors? The main competitors of Adicet Bio include ADMA Biologics (ADMA), United Rentals (URI), Fastenal (FAST), W.W. Grainger (GWW), Watsco (WSO), Applied Industrial Technologies (AIT), WESCO International (WCC), Beacon Roofing Supply (BECN), Air Lease (AL), and GATX (GATX). Adicet Bio vs. Its Competitors ADMA Biologics United Rentals Fastenal W.W. Grainger Watsco Applied Industrial Technologies WESCO International Beacon Roofing Supply Air Lease GATX Adicet Bio (NASDAQ:ACET) and ADMA Biologics (NASDAQ:ADMA) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, analyst recommendations, valuation, profitability, risk, institutional ownership and media sentiment. Which has preferable earnings & valuation, ACET or ADMA? ADMA Biologics has higher revenue and earnings than Adicet Bio. Adicet Bio is trading at a lower price-to-earnings ratio than ADMA Biologics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdicet Bio$24.99M2.57-$117.12M-$1.30-0.60ADMA Biologics$459.38M9.00$197.67M$0.8520.36 Does the media favor ACET or ADMA? In the previous week, ADMA Biologics had 2 more articles in the media than Adicet Bio. MarketBeat recorded 8 mentions for ADMA Biologics and 6 mentions for Adicet Bio. ADMA Biologics' average media sentiment score of 1.29 beat Adicet Bio's score of 0.57 indicating that ADMA Biologics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adicet Bio 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ADMA Biologics 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders hold more shares of ACET or ADMA? 83.9% of Adicet Bio shares are owned by institutional investors. Comparatively, 75.7% of ADMA Biologics shares are owned by institutional investors. 7.8% of Adicet Bio shares are owned by company insiders. Comparatively, 3.5% of ADMA Biologics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has more risk and volatility, ACET or ADMA? Adicet Bio has a beta of 1.62, suggesting that its share price is 62% more volatile than the S&P 500. Comparatively, ADMA Biologics has a beta of 0.43, suggesting that its share price is 57% less volatile than the S&P 500. Is ACET or ADMA more profitable? ADMA Biologics has a net margin of 45.01% compared to Adicet Bio's net margin of 0.00%. ADMA Biologics' return on equity of 47.16% beat Adicet Bio's return on equity.Company Net Margins Return on Equity Return on Assets Adicet BioN/A -59.05% -50.66% ADMA Biologics 45.01%47.16%30.51% Do analysts recommend ACET or ADMA? Adicet Bio presently has a consensus target price of $6.00, suggesting a potential upside of 673.49%. ADMA Biologics has a consensus target price of $27.67, suggesting a potential upside of 59.83%. Given Adicet Bio's higher probable upside, equities analysts plainly believe Adicet Bio is more favorable than ADMA Biologics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adicet Bio 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00ADMA Biologics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 SummaryADMA Biologics beats Adicet Bio on 11 of the 16 factors compared between the two stocks. Get Adicet Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ACET and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ACET and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACET vs. The Competition Export to ExcelMetricAdicet BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$67.52M$3.06B$5.70B$9.48BDividend YieldN/A2.37%4.59%3.99%P/E Ratio-0.6020.7327.9019.95Price / Sales2.57321.12442.19102.72Price / CashN/A43.2336.5558.97Price / Book0.348.308.635.90Net Income-$117.12M-$55.19M$3.24B$258.42M7 Day Performance-1.81%5.07%3.22%1.94%1 Month Performance18.57%17.61%10.72%12.02%1 Year Performance-46.50%7.03%34.94%20.81% Adicet Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACETAdicet Bio2.6878 of 5 stars$0.78-5.0%$6.00+673.5%-43.3%$67.52M$24.99M-0.6090News CoverageAnalyst UpgradeAnalyst RevisionGap DownADMAADMA Biologics3.7843 of 5 stars$18.68+0.9%$27.67+48.1%+25.0%$4.46B$426.45M21.98530News CoveragePositive NewsURIUnited Rentals4.3267 of 5 stars$809.74-0.6%$768.54-5.1%+7.9%$52.63B$15.35B20.9727,900Trending NewsEarnings ReportDividend AnnouncementAnalyst ForecastGap UpFASTFastenal4.463 of 5 stars$45.07+4.2%$48.45+7.5%+39.7%$51.71B$7.55B44.8523,702High Trading VolumeGWWW.W. Grainger3.3937 of 5 stars$1,057.72-0.2%$1,116.25+5.5%+9.9%$50.81B$17.17B27.1626,000Positive NewsWSOWatsco3.1071 of 5 stars$472.30+0.5%$484.17+2.5%-3.5%$19.13B$7.62B36.307,295Upcoming EarningsAITApplied Industrial Technologies4.0388 of 5 stars$256.95+1.2%$285.00+10.9%+27.3%$9.79B$4.50B25.806,500Positive NewsWCCWESCO International4.1871 of 5 stars$198.38-0.3%$212.63+7.2%+24.0%$9.68B$21.82B15.0120,000Upcoming EarningsBECNBeacon Roofing Supply1.1783 of 5 stars$124.17flat$124.78+0.5%N/A$7.67B$9.76B21.237,480ALAir Lease4.7549 of 5 stars$59.05+0.5%$59.29+0.4%+19.8%$6.60B$2.81B10.32150Positive NewsGATXGATX2.3936 of 5 stars$159.04+0.7%$167.67+5.4%+14.7%$5.68B$1.63B20.162,150Positive NewsUpcoming Earnings Related Companies and Tools Related Companies ADMA Alternatives URI Alternatives FAST Alternatives GWW Alternatives WSO Alternatives AIT Alternatives WCC Alternatives BECN Alternatives AL Alternatives GATX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACET) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredStrait of Hormuz = $100 Oil?Dow Drops 540 Points, Oil Soars Middle East conflict sends markets plunging, oil jumping 8.5%. Investors fl...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adicet Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adicet Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
